December 6, 2022, the Board of Trustees of Brandywine Realty Trust, upon the recommendation of the Corporate Governance Committee, appointed Joan Lau, PhD as a Trustee of its Board, effective February 1, 2023, to serve until its 2023 annual meeting of shareholders and until her successor is elected and qualified. Concurrent with her appointment to the Board, Ms. Lau was appointed to the Audit Committee of its Board. Ms. Lau brings to the Board more than 20 years of executive leadership experience, including as chief executive officer, chief operating officer and director.

In 2016, Ms. Lau co-foundedTalee Bio, a company that developed gene therapies for cystic fibrosis and later became Spirovant Sciences Inc., a company focused on the discovery and development of gene therapies for genetic respiratory diseases, and Ms. Lau became, and continues as, its Chief Executive Officer and a director. In 2013, Ms. Lau co-foundedMilitia Hill Ventures, where she is currently a Partner. Ms. Lau is also a director of Renovacor, the Philadelphia Orchestra and Kimmel Center and RiboNova Inc., in addition to serving on the Finance Committee of the Philadelphia Cricket Club, serving as an Advisor of Recharge & Recover PHL, PHL Chamber of Commerce and serving as a Board Advisor of the University of Pennsylvania School of Social Policy and Practice.